Los puntos clave no están disponibles para este artículo en este momento.
Immunotherapy, also known as immune checkpoint inhibition , has revolutionized oncology care. Many metastatic malignancies, such as melanoma and lung, bladder, and kidney cancer, that were previously fatal within months of diagnosis can now be treated with therapies that result in long-term survival
Anna N. Wilkinson (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: